Across TCGA pan-cancer cohorts, RN7SKP298 RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated RN7SKP298 data layer.
The strongest signal is observed in esophageal carcinoma (ESCA), where higher RN7SKP298 RNA is associated with better overall survival. In most high-consensus cancer types, elevated RN7SKP298 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.
ESCA are the cancer types where RN7SKP298 RNA most reproducibly stratifies survival.